Felix Sahm, MD/PhD, Prof.

Department of Neuropathology, University Hospital Heidelberg, and Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK) and German Cancer Research Center (DKFZ)
Heidelberg, Germany

Felix Sahm, MD, PhD is neuropathologist at the Dept. of Neuropathology at the University Hospital Heidelberg and head of the Division Molecular Neuropathology.

His research focuses on the identification of novel clinically relevant subgroups of brain tumors beyond the variants that can be distinguished by histology. Subsequently, he implements novel molecular markers accurately stratifying for these subgroups into diagnostic routine. Dr. Sahm performs central and reference molecular neuropathology for various studies on pediatric and adult brain tumors. His work includes studies elucidating that gliomas histologically presenting as oligoastrocytoma can molecularly be assigned to either astrocytoma or oligodendroglioma, the study establishing the prognostic role of TERT promoter mutations in meningioma, or the study devising an epigenetic classification of meningiomas. Currently, he further investigates the molecular landscape of meningioma on different levels in order to integrate molecular markers into diagnostic work-up and treatment decisions.